Ledger.Open graph →
SEC Form D · Amendment · filed July 15, 2020

Renibus Therapeutics, Inc

Offering
$35.0M
Sold
$19.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTHLAKE, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Alvaro Guillem · Southlake, TXExec · DirectorD. J. Keyser · Southlake, TXExec · DirectorHenrik J. Rasmussen · Southlake, TXDirectorBhupinder J. Singh · Southlake, TXDirectorRobert K. Grunewald · Jackson, WYDirectorMarshall H. Durston · Jackson, WYDirectorRyan K. Ripp · Jackson, WYExec · DirectorMichael C. Mcghee · New York, NYExec · DirectorLisa Henthorne · Quebec City, Quebec, CanadaDirectorRichard Hoel · Quebec City, Quebec, CanadaDirectorLouis Veronneau · Quebec City, Quebec, CanadaExec · DirectorPierre Cote · Quebec City, Quebec, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗